research and development
Edinburgh BioQuarter appoints commercialisation director
March 16, 2010Research and Development Edinburgh BioQuarter, appointment, research and development
Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation. He will lead a …
GSK promotes Jean Stephenne to chairman, biologicals
March 15, 2010Research and Development, Sales and Marketing GlaxoSmithKline, appointment, research and development, sales and marketing
GlaxoSmithKline has appointed Jean Stephenne chairman of GSK Biologicals, the company’s global vaccines division.He is currently president and general manager of …
Lamberto Andreotti new head of Bristol-Myers Squibb
March 4, 2010Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing
Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …
Kinex Pharmaceuticals appoints Rudolf Kwan
March 2, 2010Research and Development Kinex Pharmaceuticals, appointment, research and development
Dr Rudolf Kwan has joined Buffalo, US-based Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …
Lilly UK appoints Ramona Sequeira managing director
February 23, 2010Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing
Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Clinipace appoints Bud Owen and Daryl Porter
February 19, 2010Research and Development Clinipace, appointment, research and development
CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …
Dr Jay Feingold joins Daiichi Sankyo
February 19, 2010Research and Development Daiichi Sankyo, appointment, research and development
Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …
Wyeth’s Dr Graham Cook joins British Pharmacopoeia Commission
February 18, 2010Research and Development, Sales and Marketing Wyeth Pharmaceuticals, appointment, research and development, sales and marketing
Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …
Dr Steven Leventer to head up neuroscience research for PharmaNet
February 17, 2010Research and Development PharmaNet, appointment, research and development
PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …
Amarin appoints Jan van Heek
February 15, 2010Research and Development, Sales and Marketing Amarin, appointment, research and development, sales and marketing
Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …
ICON promotes Tom O’Leary
February 9, 2010Research and Development ICON, appointment, research and development
Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …
Miguel Forte joins TxCell
February 5, 2010Research and Development TxCell, appointment, research and development
French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …
Cell Medica bolsters senior management
January 28, 2010Research and Development Cell Medica, appointment, research and development
London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …
BioCeramic Therapeutics appoints Ian Brown
January 27, 2010Research and Development BioCeramic Therapeutics, appointment, research and development
BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …
Clavis Pharma appoints Olav Hellebø
January 25, 2010Research and Development, Sales and Marketing Clavis Pharma, appointment, research and development, sales and marketing
Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …
Latest content
Five Facts about cardiovascular disease
